AzTrials
AzTrials

LonelinessVRTNCT07644416

Using Virtual Reality Travel to Reduce Loneliness in Older Adults

A study testing Virtual Reality Travel in people with Loneliness and Older Adults (65 Years and Older), run by Indiana University at 3 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to investigate whether and how virtual reality travel (VRT) can reduce loneliness among older adults. It will utilize a mixed-methods research design that combines an randomly assigned experiment with follow-up semi-structured interviews. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
What is being tested?
Virtual Reality Travel
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
3 sitesUnited States
Study dates
1 Jun 2026to 30 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Adults aged 65 years or older
  • Express willingness to engage with VR technology

Who cannot join

  • No self-reported physical, sensory, neurological, or cognitive conditions that would make VR use unsafe or impractical (e.g., uncontrolled seizures, severe vertigo, or significant uncorrected vision/hearing impairments).

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Ruiping Ren contact

812-671-4087

renruip@iu.edu

United States3 sites, 3 recruiting
  • Evergreen Village at Bloomington

    Bloomington, Indiana, 47401

    Sherri Ganka, 812-336-2718, resident.services@evergreenvillage-bloomington.com

    Recruiting
  • Bell Trace

    Bloomington, Indiana, 47408

    Melissa Davis, 812-332-2355, mdavis@cardon.us

    Recruiting
  • Area 10 Agency on Aging

    Ellettsville, Indiana, 47429

    Amy Guerrettaz, 812-935-2582, aguerrettaz@area10agency.org

    Recruiting

Other trials in United States

About this study

Official title: Virtual Reality Travel (VRT) as a Loneliness Intervention for Older Adults: A Pilot Randomized Controlled Trial

This study aims to investigate whether and how virtual reality travel (VRT) can reduce loneliness among older adults. It will utilize a mixed-methods research design that combines an randomly assigned experiment with follow-up semi-structured interviews.

This is a pilot study and it is essential to establish the feasibility and acceptability of the protocol, assess the tolerability of VR technology in this population prior to conducting a full-scale RCT, and generate preliminary effect size estimates to inform future sample size calculations.

Being tested
Virtual Reality Travel, Puzzle-Based Attention Control Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality TravelBehavioural

    Participants in the VR travel group experience a 13-minute-and-44-second VR tour of Bali Island, Indonesia.

  • Puzzle-Based Attention Control ActivityBehavioural

    Participants in the attention control group complete 13 minutes and 44 seconds symmetric puzzles featuring leaves, birds, and insects.

Study groups in NCT07644416
Study groupRoleWhat they receive
Virtual reality travel groupExperimentalParticipants in the VR travel group experience a 13-minute-and-44-second VR tour of Bali Island, Indonesia.
Receives: Behavioral: Virtual Reality Travel
Attention control groupActive comparatorParticipants in the attention control group complete 13-minute-and-44-second symmetric puzzles featuring leaves, birds, and insects.
Receives: Behavioral: Puzzle-Based Attention Control Activity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. loneliness

    Loneliness was assessed using a multi-item visual analog scale (VAS), with items presented as 100 mm horizontal lines anchored by "Not at all" (left) and "Extremely" (right). Items were adapted from the University of California, Los Angeles Loneliness Scale and modified to capture present-moment experience using a "Right now…" stem, enabling assessment of state-level rather than trait-level loneliness.

    Participants were instructed to indicate their current feelings by placing a single perpendicular mark on each line corresponding to their response. VAS scores were calculated by measuring the distance in millimeters from the left anchor to the participant's mark, yielding a continuous score ranging from 0 to 100 for each item. Item scores were then averaged to compute an overall loneliness score, with higher values indicating higher levels of state loneliness.

    Measured: Baseline and following completion of the intervention session (approximately 20-30 minutes after baseline assessment)

Secondary outcomes (2)
  1. positive emotions

    Positive emotions was assessed using the Positive and Negative Affect Schedule (PANAS). The PANAS consists of 20 items, including 10 items measuring positive affect (e.g., interested, excited, enthusiastic) and 10 items measuring negative affect (e.g., distressed, upset, nervous). Participants were asked to indicate the extent to which they were experiencing each emotion right now on a Likert-type scale ranging from 1 (Very slightly or not at all) to 5 (Extremely), consistent with the state version of the measure. Scores for positive affect and negative affect were computed separately by averaging the corresponding items, with higher scores indicating greater levels of the respective emotional state.

    Measured: Baseline and following completion of the intervention session (approximately 20-30 minutes after baseline assessment)

  2. meaning in life

    Meaning in life was assessed using a modified version of the Multidimensional Existential Meaning Scale. To capture state meaning in life, the phrase "right now" was added to each item to reflect participants' momentary perceptions. The MEMS is a 15-item multidimensional measure based on a tripartite conceptualization of meaning in life encompassing comprehension (life coherence), purpose (goal-directedness), and mattering (perceived significance). Participants rated each item on a 7-point Likert scale ranging from 1 (very strongly disagree) to 7 (very strongly agree). Each subscale consists of five items, and subscale scores were computed by averaging corresponding items, with one mattering item reverse scored. Higher scores indicate greater levels of comprehension, purpose, and mattering.

    Measured: Baseline and following completion of the intervention session (approximately 20-30 minutes after baseline assessment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2026
  2. Study start1 Jun 2026
  3. Primary completion30 Dec 2026 (estimated)
  4. Study completion30 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07644416
Sponsor's protocol ID
IUB-VRTPilot-2026
Acronym
VRT
Status last verified
Aug 2026
First submitted
25 May 2026
Last updated
14 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Travel in people with Loneliness and Older Adults (65 Years and Older), run by Indiana University at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ruiping Ren (812-671-4087, renruip@iu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

loneliness (time frame: Baseline and following completion of the intervention session (approximately 20-30 minutes after baseline assessment)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in